{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T16:00:12Z","timestamp":1786723212545,"version":"build-2736575974"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["NIHR200915"],"award-info":[{"award-number":["NIHR200915"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["203141\/Z\/16\/Z"],"award-info":[{"award-number":["203141\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,12,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The incidence of bloodstream infections (BSIs) caused by Escherichia coli and Klebsiella pneumoniae is increasing, with substantial associated morbidity, mortality, and antimicrobial resistance. Unbiased serotyping studies to guide vaccine target selection are limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted unselected, population-level genomic surveillance of bloodstream E. coli and Klebsiella pneumoniae isolates from 2008 to 2018 in Oxfordshire, United Kingdom. We supplemented this with an analysis of publicly available global sequencing data (n\u2005=\u20053678).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We sequenced 3478 E. coli isolates (3278 passed quality control) and 556 K. pneumoniae isolates (535 [K-antigen] and 549 [O-antigen] passed quality control). The 4 most common E. coli O-antigens (O1\/O2\/O6\/O25) were identified in 1499\/3278 isolates; the incidence of these O-types increased over time (incidence rate ratio per year [IRRy]\u2005=\u20051.14, 95% confidence interval [CI]: 1.11\u20131.16). These O-types accounted for 616\/1434 multidrug-resistant (MDR) and 173\/256 extended-spectrum beta-lactamase (ESBL)-resistant isolates in Oxfordshire but only 19\/90 carbapenem-resistant isolates across all studies. For Klebsiella pneumoniae, the most common O-antigens (O2v2\/O1v1\/O3b\/O1v2) accounted for 410\/549 isolates; the incidence of BSIs caused by these also increased annually (IRRy\u2005=\u20051.09; 95% CI: 1.05\u20131.12). These O-types accounted for 122\/148 MDR and 106\/123 ESBL isolates in Oxfordshire and 557\/734 carbapenem-resistant isolates across all studies. Conversely we observed substantial capsular antigen diversity. Analysis of 3678 isolates from global studies demonstrated the generalizability of these findings. For E. coli, based on serotyping, the ExPEC4V and ExPEC10V vaccines under investigation would cover 46% and 72% of Oxfordshire isolates respectively, and 47% and 71% of MDR isolates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>O-antigen targeted vaccines may be useful in reducing the morbidity, mortality, and antimicrobial resistance associated with E. coli and K. pneumoniae BSIs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/cid\/ciab006","type":"journal-article","created":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T17:19:15Z","timestamp":1609953555000},"page":"2276-2282","source":"Crossref","is-referenced-by-count":34,"title":["Ten Years of Population-Level Genomic\n                    <i>Escherichia coli<\/i>\n                    and\n                    <i>Klebsiella pneumoniae<\/i>\n                    Serotype Surveillance Informs Vaccine Development for Invasive Infections"],"prefix":"10.1093","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5872-9214","authenticated-orcid":false,"given":"Samuel","family":"Lipworth","sequence":"first","affiliation":[{"name":"Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom"},{"name":"Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina-Doris","family":"Vihta","sequence":"additional","affiliation":[{"name":"Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin K","family":"Chau","sequence":"additional","affiliation":[{"name":"Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Kavanagh","sequence":"additional","affiliation":[{"name":"Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Davies","sequence":"additional","affiliation":[{"name":"Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom"},{"name":"Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"George","sequence":"additional","affiliation":[{"name":"Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leanne","family":"Barker","sequence":"additional","affiliation":[{"name":"Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Vaughan","sequence":"additional","affiliation":[{"name":"Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique","family":"Andersson","sequence":"additional","affiliation":[{"name":"Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Jeffery","sequence":"additional","affiliation":[{"name":"Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Oakley","sequence":"additional","affiliation":[{"name":"Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Morgan","sequence":"additional","affiliation":[{"name":"Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy E A","family":"Peto","sequence":"additional","affiliation":[{"name":"Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom"},{"name":"NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at University of Oxford in partnership with Public Health England, Oxford, United Kingdom"},{"name":"NIHR Biomedical Research Centre, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derrick W","family":"Crook","sequence":"additional","affiliation":[{"name":"Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom"},{"name":"Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom"},{"name":"NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at University of Oxford in partnership with Public Health England, Oxford, United Kingdom"},{"name":"NIHR Biomedical Research Centre, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A Sarah","family":"Walker","sequence":"additional","affiliation":[{"name":"Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom"},{"name":"NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at University of Oxford in partnership with Public Health England, Oxford, United Kingdom"},{"name":"NIHR Biomedical Research Centre, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Stoesser","sequence":"additional","affiliation":[{"name":"Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom"},{"name":"Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,1,7]]},"reference":[{"key":"2021121701502143600_CIT0001","doi-asserted-by":"crossref","first-page":"e013665","DOI":"10.1136\/bmjopen-2016-013665","article-title":"Incidence of bloodstream infections: a nationwide surveillance of acute care hospitals in Switzerland 2008\u20132014","volume":"7","author":"Buetti","year":"2017","journal-title":"BMJ Open"},{"key":"2021121701502143600_CIT0002","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00355-19","article-title":"The microbiology of bloodstream infection: 20-year trends from the SENTRY antimicrobial surveillance program","author":"Diekema","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2021121701502143600_CIT0003","doi-asserted-by":"crossref","first-page":"ofaa472","DOI":"10.1093\/ofid\/ofaa472","article-title":"Trends in bacteremia over 2 decades in the top end of the northern territory of Australia","volume":"7","author":"Douglas","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"2021121701502143600_CIT0004","year":"2019"},{"key":"2021121701502143600_CIT0005","volume-title":"The Health and Social Care Act 2008 Code of Practice of the prevention and control of infections and related guidance","author":"DHSC","year":"2015"},{"key":"2021121701502143600_CIT0006","year":"2017"},{"key":"2021121701502143600_CIT0007","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/infdis\/jiv429","article-title":"Extraintestinal pathogenic Escherichia coli, a common human pathogen: challenges for vaccine development and progress in the field","volume":"213","author":"Poolman","year":"2016","journal-title":"J Infect Dis"},{"key":"2021121701502143600_CIT0008","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S1473-3099(18)30803-X","article-title":"Safety and immunogenicity of a vaccine for extra-intestinal pathogenic Escherichia coli (ESTELLA): a phase 2 randomised controlled trial","volume":"19","author":"Frenck","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2021121701502143600_CIT0009"},{"key":"2021121701502143600_CIT0010","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1080\/14760584.2019.1635460","article-title":"Progress towards the development of Klebsiella vaccines","volume":"18","author":"Choi","year":"2019","journal-title":"Expert Rev Vaccines"},{"key":"2021121701502143600_CIT0011","first-page":"e000064","article-title":"In silico serotyping of E. coli from short read data identifies limited novel O-loci but extensive diversity of O:H serotype combinations within and between pathogenic lineages","volume":"2","author":"Ingle","year":"2016","journal-title":"Microb Genom"},{"key":"2021121701502143600_CIT0012","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.3389\/fmicb.2019.01530","article-title":"Sequence types, clonotypes, serotypes, and virotypes of extended-spectrum \u03b2-lactamase-producing Escherichia coli causing bacteraemia in a Spanish hospital over a 12-year period (2000 to 2011)","volume":"10","author":"Mamani","year":"2019","journal-title":"Front Microbiol"},{"key":"2021121701502143600_CIT0013","first-page":"e000073","article-title":"The diversity of Klebsiella pneumoniae surface polysaccharides","volume":"2","author":"Follador","year":"2016","journal-title":"Microb Genom"},{"key":"2021121701502143600_CIT0014","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.3389\/fmicb.2020.01249","article-title":"The diversity of lipopolysaccharide (O) and capsular polysaccharide (K) antigens of invasive Klebsiella pneumoniae in a multi-country collection","volume":"11","author":"Choi","year":"2020","journal-title":"Front Microbiol"},{"key":"2021121701502143600_CIT0015","article-title":"Comparison of long-read sequencing technologies in the hybrid assembly of complex bacterial genomes","volume":"5","author":"De Maio","year":"2019","journal-title":"Microb Genom"},{"key":"2021121701502143600_CIT0016","article-title":"Genomic profiling of Escherichia coli isolates from bacteraemia patients: a 3-year cohort study of isolates collected at a Sydney teaching hospital","volume":"6","author":"Hastak","year":"2020","journal-title":"Microb Genom"},{"key":"2021121701502143600_CIT0017","doi-asserted-by":"crossref","DOI":"10.1101\/gr.216606.116","article-title":"Systematic longitudinal survey of invasive Escherichia coli in England demonstrates a stable population structure only transiently disturbed by the emergence of ST131","author":"Kallonen","year":"2017","journal-title":"Genome Res"},{"key":"2021121701502143600_CIT0018","doi-asserted-by":"crossref","first-page":"e0227604","DOI":"10.1371\/journal.pone.0227604","article-title":"Extended-spectrum beta-lactamase (ESBL)-producing and non-ESBL-producing Escherichia coli isolates causing bacteremia in the Netherlands (2014\u20132016) differ in clonal distribution, antimicrobial resistance gene and virulence gene content","volume":"15","author":"van Hout","year":"2020","journal-title":"PLoS One"},{"key":"2021121701502143600_CIT0019","doi-asserted-by":"crossref","DOI":"10.1099\/mgen.0.000190","article-title":"Genetic analysis of invasive Escherichia coli in Scotland reveals determinants of healthcare-associated versus community-acquired infections","author":"Goswami","year":"2018","journal-title":"Microb Genom"},{"key":"2021121701502143600_CIT0020","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13073-019-0706-y","article-title":"Genomic surveillance for hypervirulence and multi-drug resistance in invasive Klebsiella pneumoniae from South and Southeast Asia","volume":"12","author":"Wyres","year":"2020","journal-title":"Genome Med"},{"key":"2021121701502143600_CIT0021","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s13059-019-1785-1","article-title":"Contrasting patterns of longitudinal population dynamics and antimicrobial resistance mechanisms in two priority bacterial pathogens over 7 years in a single center","volume":"20","author":"Ellington","year":"2019","journal-title":"Genome Biol"},{"key":"2021121701502143600_CIT0022","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1473-3099(16)30257-2","article-title":"Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study","volume":"17","author":"Grundmann","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"2021121701502143600_CIT0023","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1038\/s41564-019-0492-8","article-title":"Epidemic of carbapenem-resistant Klebsiella pneumoniae in Europe is driven by nosocomial spread","volume":"4","author":"David","year":"2019","journal-title":"Nat Microbiol"},{"key":"2021121701502143600_CIT0024","doi-asserted-by":"crossref","first-page":"524","DOI":"10.2307\/2532940","article-title":"Applying Cox regression to competing risks","volume":"51","author":"Lunn","year":"1995","journal-title":"Biometrics"},{"key":"2021121701502143600_CIT0025","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1741-7015-12-40","article-title":"Classification of healthcare-associated infection: a systematic review 10 years after the first proposal","volume":"12","author":"Cardoso","year":"2014","journal-title":"BMC Med"},{"key":"2021121701502143600_CIT0026","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/S1473-3099(18)30353-0","article-title":"Trends over time in Escherichia coli bloodstream infections, urinary tract infections, and antibiotic susceptibilities in Oxfordshire, UK, 1998\u20132016: a study of electronic health records","volume":"18","author":"Vihta","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"2021121701502143600_CIT0027","author":"Seemann"},{"key":"2021121701502143600_CIT0028","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13073-014-0090-6","article-title":"SRST2: Rapid genomic surveillance for public health and hospital microbiology labs","volume":"6","author":"Inouye","year":"2014","journal-title":"Genome Med"},{"key":"2021121701502143600_CIT0029","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1128\/JCM.00008-15","article-title":"Rapid and easy in silico serotyping of Escherichia coli isolates by use of whole-genome sequencing data","volume":"53","author":"Joensen","year":"2015","journal-title":"J Clin Microbiol"},{"key":"2021121701502143600_CIT0030","author":"ECTyper (An Easy Typer), Github."},{"key":"2021121701502143600_CIT0031","author":"Holt"},{"key":"2021121701502143600_CIT0032","author":"EUCAST"},{"key":"2021121701502143600_CIT0033","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1093\/jac\/dkr359","article-title":"BSAC standardized disc susceptibility testing method (version 10)","volume":"66","author":"Andrews","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"2021121701502143600_CIT0034","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/joim.13007","article-title":"Hypervirulent Klebsiella pneumonia\u2013clinical and molecular perspectives","volume":"287","author":"Choby","year":"2020","journal-title":"J Intern Med"},{"key":"2021121701502143600_CIT0035","author":"Boston Consulting Group and The Wellcome Trust."}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciab006\/41389464\/ciab006.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/73\/12\/2276\/41794032\/ciab006.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/73\/12\/2276\/41794032\/ciab006.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T20:52:18Z","timestamp":1639687938000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/73\/12\/2276\/6067638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,7]]},"references-count":35,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,1,7]]},"published-print":{"date-parts":[[2021,12,16]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciab006","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.07.08.20140707","asserted-by":"object"}]},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,12,15]]},"published":{"date-parts":[[2021,1,7]]}}}